| HLA-DRB1-DQA1-DQB1 Genotype and Frequency of Enterovirus in Longitudinal Monthly Fecal Samples from Healthy Infants. | |
| | |
MedLine Citation:
|
PMID: 22691100 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Abstract Enterovirus infections may be involved in the etiology of type 1 diabetes (T1D), which is strongly associated with certain human leukocyte antigen (HLA) class II haplotypes. Our aim was to assess whether HLA genotypes conferring varying degrees of risk for T1D were associated with enterovirus gut infections. From the general Norwegian population, 190 healthy infants at high-risk for T1D (DR4-DQ8/DR3-DQ2), and 383 infants without this genotype were identified. Non-DR4-DQ8/DR3-DQ2 genotypes were further categorized as conferring either an increased-to-moderate risk (DR4-DQ8 or DR3-DQ2), were protective (DQB1*06:02), or were neutral (all other genotypes). A total of 4626 monthly fecal samples taken between age 3 and 12 mo were tested for enterovirus RNA using real-time PCR. Enterovirus prevalence was 11.5% among high-risk children, and 12.2% in other children (adjusted odds ratio: 1.23, p=0.12). The prevalence was 11.3% in those with increased-to-moderate risk, 13.0% in the protective group, and 12.6% in the neutral group (likelihood ratio test, 3 d.f.: p=0.37). In conclusion, there was no statistically significant association between HLA genotype and the occurrence of human enterovirus gut infections. |
| | |
Authors:
|
Elisabet Witsø; Ondrej Cinek; German Tapia; Trond Rasmussen; Lars C Stene; Kjersti S Rønningen |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Viral immunology Volume: 25 ISSN: 1557-8976 ISO Abbreviation: Viral Immunol. Publication Date: 2012 Jun |
Date Detail:
|
Created Date: 2012-06-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8801552 Medline TA: Viral Immunol Country: United States |
Other Details:
|
Languages: eng Pagination: 187-92 Citation Subset: IM |
Affiliation:
|
1 Norwegian Institute of Public Health , Oslo, Norway . |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Can male vaccination reduce the burden of human papillomavirus-related disease in the United States?
Next Document: Immunogenicity, Safety, and Tolerability of Two Trivalent Subunit Inactivated Influenza Vaccines: A ...